INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Sarissa Capital Management LP's Holding History (CIK: 0001577524)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 950 Value ($000) $18 Avg Close — Range —
Q1 2021
Shares 950 Value ($000) $21 Avg Close — Range —
Q4 2020
Shares 950 Value ($000) $23 Avg Close — Range —
Q3 2020
Shares 1,201,000 Value ($000) $49,793 Avg Close — Range —
Q2 2020
Shares 1,201,000 Value ($000) $57,539 Avg Close — Range —
Q1 2020
Shares 1,155,000 Value ($000) $72,718 Avg Close — Range —
Q4 2019
Shares 860,000 Value ($000) $106,571 Avg Close — Range —
Q3 2019
Shares 851,000 Value ($000) $56,472 Avg Close — Range —
Q2 2019
Shares 757,000 Value ($000) $60,234 Avg Close — Range —
Q1 2019
Shares 320,000 Value ($000) $35,795 Avg Close — Range —
Q4 2018
Shares 54,000 Value ($000) $5,442 Avg Close — Range —
Q3 2018
Shares 257,500 Value ($000) $32,537 Avg Close — Range —
Q2 2018
Shares 635,300 Value ($000) $53,308 Avg Close — Range —
Q1 2018
Shares 635,300 Value ($000) $39,083 Avg Close — Range —
Q4 2017
Shares 182,300 Value ($000) $10,649 Avg Close — Range —